`v.
`NuVasive, Inc.
`
`IPR2019-00361
`
`IPR2019-00362
`
`IPR2019-00546
`
`U.S. Patent No. 8,187,334
`
`U.S. Patent No. 8,631,156
`
`U.S. Patent No. 8,187,334
`
`Petitioners’ Presentation
`
`April 3, 2020
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`1
`
`
`
`Overview of Grounds
`Overview of Grounds
`
`2
`
`
`
`Overview of Grounds
`
`The ’334 patent (-0361)
`
`Ground
`
`Claims
`
`Basis
`
`1
`
`2
`
`6-9 and 18
`
`Obvious over Frey, Michelson, and Berry
`
`6-9 and 18
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`Ground
`
`Claims
`
`Basis
`
`The ’334 patent (-0546)
`
`1
`
`2
`
`16
`
`16
`
`Obvious over Frey, Michelson, and Baccelli
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`3
`
`
`
`Overview of Grounds
`
`The ’156 patent (-0362)
`
`Claims
`1-3, 5, 9, 10, 12-21,
`23, 24, and 27
`
`Basis
`
`Obvious over Brantigan, Baccelli, and Berry
`
`9
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`Ground
`
`1
`
`2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`4
`
`
`
`Background
`Background
`
`5
`
`
`
`Challenged Claims Directed to Spinal Fusion Implants
`
`EX1002 [Branch Decl.], ¶ 22
`
`EX1002 [Branch Decl.], ¶ 27
`
`Source: Pet. 47
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`6
`
`
`
`Challenged Claims Directed to Spinal Fusion Implants
`
`EX1002 [Branch Decl.], ¶ 27
`
`EX1001 [’334 Patent], Fig. 2 (annotated)
`
`Source: Pet., 7, 47
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`7
`
`
`
`State of the Art
`State of the Art
`
`8
`
`
`
`State of the Art
`
`• Non-bone implants were known
`
`• Modular implants were known
`
`• Vertebral dimensions were known
`
`• Radiopaque markers were known
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`9
`
`
`
`Berry Discloses Dimensions for Non-Bone Implants (1987)
`
`EX1022 [Berry], 1
`
`EX1022 [Berry], 1
`
`EX1022 [Berry], 1
`
`Source: Pet., 12-13
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`10
`
`
`
`Brantigan Discloses Non-Bone Implants (1993)
`
`EX1007 [Brantigan], 3:9-12
`
`EX1007 [Brantigan], Fig. 1
`
`Source: Pet., 15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`11
`
`
`
`Michelson Discloses Non-Bone Implants (1999)
`
`EX1032 [Michelson], 6:36-37
`
`The translateral implants of the present invention
`may be made of an artificial material.
`
`EX1032 [Michelson], Figs. 16, 18
`
`Source: Pet., 9-12
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`12
`
`
`
`Frey Discloses Non-Bone Implants (2002)
`
`EX1040 [Frey], [0181]
`
`EX1040 [Frey], Fig. 57
`
`Source: Pet., 8-9
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`13
`
`
`
`Patent Owner’s State of the Art in Current Proceedings
`
`POR, 13
`
`Source: POR, 13
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`14
`
`
`
`Patent Owner’s Statements in Prior Challenges
`
`EX1038 [IPR2013-00208 McAfee Decl.]
`
`* * *
`
`Source: IPR2019-00362 Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`15
`
`
`
`Patent Owner’s Statements in Prior Challenges
`
`EX1038 [IPR2013-00208 McAfee Decl.], ¶ 27
`
`Source: IPR2019-00362 Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`16
`
`
`
`Patent Owner Previously Relied on McAfee (1998)
`
`EX1047 [IPR2013-00208 Reply], 8
`
`* * *
`
`Source: IPR2109-00362 Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`17
`
`
`
`McAfee Discloses Non-Bone Implants (1998)
`
`EX1054 [McAfee], Fig. 5
`
`Source: Reply, 2; IPR2019-00362 Reply, 2; IPR2019-00546 Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`18
`
`
`
`Patent Owner Previously Relied on Michelson ‘770 (2001)
`
`EX1038 [IPR2013-00208 McAfee Decl.]
`
`* * *
`
`Source: IPR2109-00362 Pet. Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`19
`
`
`
`Michelson ’770 Discloses Non-Bone Implants (2001)
`
`EX1053 [Michelson ’770], 2:20-25, 2:33-36
`
`* * *
`
`Source: Reply, 4; IPR2019-00362 Reply, 4; IPR2019-00546, Reply, 4
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`20
`
`
`
`State of the Art
`
`• Non-bone implants were known
`
`• Modular implants were known
`
`• Vertebral dimensions were known
`
`• Radiopaque markers were known
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`21
`
`
`
`Brantigan Discloses Modular Implants (1993)
`
`EX1007 [Brantigan], 2:4-11
`
`Source: Pet., 61-62
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`22
`
`
`
`Michelson Discloses Modular Implants (1999)
`
`EX1032 [Michelson], 10:48-59
`
`Source: Pet., 41-42
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`23
`
`
`
`Frey Discloses Modular Implants (2002)
`
`EX1040 [Frey], [0160]
`
`Source: Pet., 42-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`24
`
`
`
`Patent Owner’s State of the Art in Current Proceedings
`
`POR, 12
`
`Source: POR, 12
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`25
`
`
`
`Patent Owner Previously Relied on McAfee (1998)
`
`EX1054 [McAfee], Fig. 5
`
`Source: Reply, 2; IPR2019-00362 Reply, 2; IPR2019-00546 Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`26
`
`
`
`Patent Owner Previously Relied on Michelson ‘770 (2001)
`
`EX1053 [Michelson ‘770], Figs. 13B, 14B
`
`Source: Reply, 10-11; Supp. Sur-Sur-Reply, 2; IPR2019-00362 Reply, 12-13; Supp. Sur-Sur-Reply, 2; IPR2019-00546 Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`27
`
`
`
`State of the Art
`
`• Non-bone implants were known
`
`• Modular implants were known
`
`• Vertebral dimensions were known
`
`• Radiopaque markers were known
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`28
`
`
`
`Berry Discloses “Direct Dimensional Measurements” (1987)
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 13, 40-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`29
`
`
`
`State of the Art
`
`• Non-bone implants were known
`
`• Modular implants were known
`
`• Vertebral dimensions were known
`
`• Radiopaque markers were known
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`30
`
`
`
`Frey Discloses Three Radiopaque Markers (2002)
`
`EX1040 [Frey], Fig. 59 (annotated)
`
`Source: Pet., 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`31
`
`
`
`Baccelli Discloses Four Radiopaque Markers (2003)
`
`EX1008 [Baccelli], Figs. 1, 2 (annotated)
`
`Source: Pet., 16
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`32
`
`
`
`Patent Owner’s State of the Art in Current Proceedings
`
`POR, 55
`
`Source: POR, 55
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`33
`
`
`
`McAfee Discloses X-Rays to Show Implant Position (1998)
`
`EX1054 [McAfee], Fig. 1
`
`Source: Reply, 3; IPR2019-00362 Reply, 2-3; IPR2019-00546 Reply, 2-3
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`34
`
`
`
`IPR2019-00361
`IPR2019-00361
`
`‘334 Patent - Ground 1
`'334 Patent - Ground 1
`
`35
`
`
`
`Overview of Grounds
`
`The ’334 patent (-0361)
`
`Ground
`
`Claims
`
`Basis
`
`1
`
`6-9 and 18
`
`Obvious over Frey, Michelson, and Berry
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`36
`
`
`
`Claim 1 of the ‘334 Patent Previously Found Invalid
`
`EX1004 [IPR2013-00507 FWD], 13
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 17
`
`Source: Pet., 17-21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`37
`
`
`
`Claim 1 of the ‘334 Patent Previously Found Invalid
`
`EX1001 [’334 patent]
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`38
`
`
`
`Collateral Estoppel Applies to Claim 1
`
`MaxLinear, Inc. v. CF CRESPE LLC, 880 F.3d, 1373, 1376 (Fed. Cir. 2018)
`
`Source: Reply, 6
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`39
`
`
`
`Previous Petitioner Relied On Different Disclosure For Claim 18
`
`EX1004 [IPR2013-00507 FWD], 10
`
`Prior Petitioner did not:
`
`• cite the same evidence Federal
`Circuit relied on to invalidate
`claim 1 for claim 18
`
`• cite Michelson’s long-and-
`narrow modular disclosure for
`claim 18
`
`Federal Circuit did not:
`
`• address Michelson’s long-and-
`narrow modular disclosure for
`claim 18
`
`• affirm patentability of claim 18
`
`Source: Pet., 17-21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`40
`
`
`
`Federal Circuit Dismissed Claim 18 Cross-Appeals
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 8
`
`Source: Pet., 21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`41
`
`
`
`Federal Circuit Dismissed Claim 18 Cross-Appeals
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 15-16
`
`Source: Pet., 21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`42
`
`
`
`Claim 1 Unpatentable Over Frey and Michelson
`
`EX1001 [’334 patent], claim 1
`
`Source: Pet., 17-21; Branch Decl. pgs. 40-56; IPR2019-00546 Pet., 31; Branch Decl. pgs. 40-56
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`43
`
`
`
`Frey, Michelson, and Berry Render Obvious Claims 6–9, 16, and 18
`
`EX1001 [’334 patent]
`
`Dependent claims directed to:
`
`• medial support
`
`• second fusion aperture
`
`• fourth radiopaque marker
`(claim 16 – IPR2019-00546)
`
`• width of approximately 18 mm
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`44
`
`
`
`Claims 6–7 and 9: Frey Discloses a “Medial Support”
`
`EX1001 [’334 Patent], claims 6-7
`
`EX1001 [’334 Patent], claim 9
`
`EX1040 [Frey], Fig. 55 (annotated)
`
`EX1040 [Frey], Fig. 63 (annotated)
`
`Source: Pet., 33-36, 38-40
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`45
`
`
`
`Claims 6–7 and 9: Frey Discloses a “Medial Support”
`
`EX1040 [Frey], [0144]
`
`EX1040 [Frey], [0154]
`
`Source: Pet., 33-36, 38-40
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`46
`
`
`
`The ‘334 Patent Claims Describe “Medial Support”
`
`EX1001 [’334 patent], claims 6-7
`
`“medial support” is not “medial plane”
`
`“medial support” need not intersect sidewalls “approximately at the midpoint”
`
`“positioned along” does not mean “proximate to the midpoint”
`
`Source: Pet., 33-36; Reply, 5-6; POR , 8-9, 51
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`47
`
`
`
`Claim 1 of the ’334 Patent Defines “Central Region”
`
`EX1001 [’334 Patent], claim 1
`
`“central region” has no midpoint
`
`Source: Reply 5-6; POR, 8.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`48
`
`
`
`Claims 8–9: Frey Discloses “Fusion Aperture”
`
`EX1001 [’334 Patent], claim 8
`
`EX1001 [’334 Patent], claim 9
`
`EX1040 [Frey], Fig. 55 (annotated)
`
`EX1040 [Frey], Fig. 63 (annotated)
`
`Source: Pet., 36-40
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`49
`
`
`
`Claims 8–9: Frey Discloses “Fusion Aperture”
`
`EX1040 [Frey], [0144]
`
`EX1040 [Frey], [0154]
`
`Source: Pet., 36-40
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`50
`
`
`
`Patent Owner’s “Medial Support” Arguments
`
`EX1040 [Frey], Fig. 59
`
`EX1001 [‘334 Patent], claims 6, 7, 9
`
`* * *
`
`“medial support” need not separate fusion apertures from upper and lower
`surfaces completely
`
`“positioned along” does not mean “on a course parallel to the central region”
`
`Source: Pet., 33-36, 38-40; POR 51; Reply, 12-13
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`51
`
`
`
`Patent Owner’s “Fusion Aperture” Arguments
`
`EX1040 [Frey], Fig. 57
`
`EX1001 [‘334 Patent], claims 1, 8
`
`* * *
`
`“at least a first fusion aperture” means “one or more”
`
`“upper openings 1018a and 1018b” and “lower openings 1020a and 1020b”
`comprise the claimed “at least a first fusion aperture”
`
`Source: Pet., 36-38; POR, 48; Reply, 11-12
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`52
`
`
`
`Claim 18: Frey, Michelson, and Berry Disclose Limitations
`
`EX1001 [’334 Patent], claim 18
`
` Frey discloses modular (multiple) implants in the disc space
`
` Michelson discloses modular, long-and-narrow implants
`
` Berry discloses vertebral dimensions
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`53
`
`
`
`Federal Circuit Recognized Michelson’s Modularity
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 13-14
`
`Source: Pet., 2-3
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`54
`
`
`
`Federal Circuit Recognized Michelson’s Modularity
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 13-14
`
`Source: Pet., 2-3
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`55
`
`
`
`NuVasive’s Argument Re Modularity to Federal Circuit
`
`EX1005 [Fed. Cir. Op. IPR2013-00507, -00508], 16
`
`Source: Pet., 17-21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`56
`
`
`
`Patent Owner’s Argument Re Modularity in Current Proceedings
`
`POR, 12
`
`Source: POR, 12
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`57
`
`
`
`Patent Owner’s Expert Dr. Youssef Re Modularity
`
`EX2055 [Youssef Decl.], ¶ 92
`
`Source: POR, 36
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`58
`
`
`
`Patent Owner’s Expert Dr. McMillin Re Modularity
`
`EX1051 [McMillin Dep. Tr.], 54:2–17
`
`Source: Reply, 10
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`59
`
`
`
`Patent Owner’s Argument Against 18 mm Width
`
`POR, 51
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`60
`
`
`
`Claim 18: Frey Discloses Modular Implants
`
`EX1040 [Frey], [0160]
`
`Source: Pet., 42-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`61
`
`
`
`Claim 18: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], 10:48-59
`
`Source: Pet., 40-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`62
`
`
`
`Claim 18: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], 5:34-39
`
`Source: Reply, 10
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`63
`
`
`
`Claim 18: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], Figs. 16, 18, 19
`
`Source: Pet., 40-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`64
`
`
`
`Claim 18: Michelson’s Width "approximates depth of the vertebrae”
`
`EX1032 [Michelson], 10:36-40
`
`Source: Pet., 30
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`65
`
`
`
`Claim 18: Frey, Michelson, and Berry Disclose Limitations
`
`EX1001 [’334 Patent], claim 18
`
`EX1022 [Berry], Table 1
`
`Petitioner never suggested inserting 2
`implants each having 18.95 mm width
`
`L4-L5 Implant Width Range
`L4 (lower (“D”)) –> (35.6 – 3.1) / 2 = 16.25 mm*
`L5 (upper (“E”)) –> (35.1 + 2.8) / 2 = 18.95 mm
`
`Longitudinal Length
`L4 (lower (“C”)) –> 50.9 – 4.6 = 46.3 mm, which is “at least two and a half
`times greater than said maximum lateral width” as required by claim 1
`
`*The value “16.15 mm” at Petition 42 should
`properly be 16.25 mm as calculated above.
`
`Source: Pet., 40-43; Reply, 9-10
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`66
`
`
`
`Motivation to Combine
`Frey, Michelson, and Berry
`
`67
`
`
`
`Obviousness Analysis Requires Assessment of Background Knowledge
`
`Pet. Sup. Sur-Sur Reply, 1
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`68
`
`
`
`Motivation to Combine: Modular Implants with Vertebral Dimensions
`
`EX1040 [Frey], [0160]
`
`EX1032 [Michelson], Fig. 19
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 30-31
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`69
`
`
`
`Motivation to Combine: Increased Safety and Decreased Invasiveness
`
`EX1040 [Frey], [0183]
`
`EX1032 [Michelson], 3:61-65
`
`Source: Pet., 30; Reply, 8-9
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`70
`
`
`
`Motivation to Combine: Increased Safety and Decreased Invasiveness
`
`Pet., 31
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`71
`
`
`
`Patent Owner’s Argument Against Motivation to Combine
`
`POR, 44-45
`
`Source: POR, 44-45
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`72
`
`
`
`Patent Owner’s Expert Dr. Youssef on State of the Art
`
`EX1050, 57:12-22
`
`Source: Supp. Sur-Sur-Reply, 2; IPR2019-00362 Supp. Sur-Sur-Reply, 2; IPR2019-00546 Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`73
`
`
`
`Obviousness Analysis Requires Assessment of Background Knowledge
`
`Koninklijke Philips N.V. v. Google LLC, 948 F.3d 1330, 1337 (Fed. Cir. 2020)
`
`Source: Supp. Sur-Sur-Reply, 1
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`74
`
`
`
`POSAs Aware of Side-By-Side Lateral Insertion of Non-Bone Implants
`
`EX1054 [McAfee], Fig. 5
`
`EX1054 [McAfee], Fig. 4
`
`Source: Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`75
`
`
`
`IPR2019-00361
`IPR2019-00361
`
`’334 Patent - Ground 2
`'334 Patent - Ground 2
`
`76
`
`
`
`Overview of Grounds
`
`The ’334 patent (-0361)
`
`Ground
`
`Claims
`
`Basis
`
`2
`
`6-9 and 18
`
`Obvious over Brantigan, Baccelli,
`Berry, and Michelson
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`77
`
`
`
`Claim 1: Brantigan Discloses a “Spinal Fusion Implant”
`
`EX1001 [’334 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`Source: Pet., 48-52
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`78
`
`
`
`Claim 1: Brantigan Discloses a “Spinal Fusion Implant”
`
`EX1007 [Brantigan], 4:1-14
`
`Source: Pet., 48-52
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`79
`
`
`
`Claim 1: Brantigan Discloses a “Spinal Fusion Implant”
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`EX1007 [Brantigan], 3:30-35
`
`Source: Pet., 56-57, 61-64
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`80
`
`
`
`Claim 1: Brantigan Discloses Claimed “Central Region”
`
`EX1001 [’334 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`Source: Pet., 48-52
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`81
`
`
`
`Claim 1: Brantigan Discloses Claimed “Central Region”
`
`EX1007 [Brantigan], 4:1-14
`
`EX1007 [Brantigan], 5:36-43
`
`Source: Pet., 48-52
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`82
`
`
`
`Claim 1: Brantigan, Michelson, and Berry Disclose Claimed Dimensions
`
`EX1001 [’334 Patent], claim 1
`
`EX1001 [’334 Patent], claim 1
`
`Source: Pet., 56-57, 61-64
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`83
`
`
`
`Claim 1: Brantigan, Michelson, and Berry Disclose Claimed Dimensions
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`EX1007 [Brantigan], 3:30-35
`
`EX1007 [Brantigan], 1:18-21
`
`EX1007 [Brantigan], 1:68-2:4
`
`Source: Pet., 56-57, 61-64
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`84
`
`
`
`Claim 1: Brantigan Discloses Modular Implants
`
`EX1007 [Brantigan], 2:7-11
`
`Source: Pet., 61-62
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`85
`
`
`
`Claim 1: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], 5:34-39
`
`Source: Reply, 10
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`86
`
`
`
`Claim 1: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], Figs. 16, 18, & 19
`
`Source: Pet., 61-62
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`87
`
`
`
`Claim 1: Michelson’s Width "approximates depth of the vertebrae”
`
`EX1032 [Michelson], 10:36-40
`
`Source: Pet., 62
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`88
`
`
`
`Claim 1: Brantigan, Michelson, and Berry Disclose Claimed Dimensions
`
`EX1001 [’334 Patent], claim 1
`
`EX1001 [’334 Patent], claim 1
`
`EX1022 [Berry], Table 1
`
`L4-L5 Implant Width Range
`L4 (lower (“D”)) –> (35.6 – 3.1) / 2 = 16.25 mm*
`L5 (upper (“E”)) –> (35.1 + 2.8) / 2 = 18.95 mm
`
`Longitudinal Length
`L4 (lower (“C”)) –> 50.9 – 4.6 = 46.3 mm, which is “at least two and a
`half times greater than said maximum lateral width”
`
`* The value “16.15 mm” at Petition 63 should
`properly be 16.25 mm as calculated above
`
`Source: Pet., 61-64
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`89
`
`
`
`Claim 1: Brantigan Discloses Claimed “Fusion Aperture”
`
`EX1001 [’334 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`POR: Fig. 1 is “unassembled precursor”
`requiring connecting bar 15
`
`• Brantigan does not require connecting bar
`• In any case, aperture length is greater than
`aperture width
`Source: Pet., 64-66; Reply 14-15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`90
`
`
`
`Brantigan’s Implants Do Not Require Connecting Bar 15
`
`EX1007 [Brantigan] claim 10
`
`EX1007 [Brantigan] claim 12
`
`Source: Reply, 14-15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`91
`
`
`
`Claim 1: Baccelli Discloses Claimed Markers
`
`
`
`EX1001 [‘334 Patent], claim 1EX1001 [’334 Patent], claim 1
`
`Baccelli is not mis-labeled
`
`Longitudinal length defined by insertion
`
`Pet., 45 citing Ex. 1008, Figs. 1–2 (annotated)
`
`Source: Pet., 22-24, 67-70
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`92
`
`
`
`Federal Circuit: Implant “Length” is “Insertion” to “Trailing” End
`
`EX1019 [Fed. Cir. Op. IPR2013-00206 re Michelson ‘997 Patent], 5
`
`Source: Pet., 22-24
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`93
`
`
`
`Patent Owner’s Expert Dr. Youssef on Insertion Path
`
`EX1050 [Youssef Dep. Tr.], 23:9-17
`
`Source: Pet., 22-24, Reply, 5
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`94
`
`
`
`Patent Owner’s Expert Dr. McMillin on Insertion Path
`
`EX1051 [McMillin Dep. Tr.], 43:13-20, 44:21-25
`
`Source: Pet., 22-24; Reply, 5
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`95
`
`
`
`Claim 1: Baccelli Discloses Claimed Markers
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 67–70
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`96
`
`
`
`Claims 6–9: Brantigan Discloses Limitations
`
`EX1001 [’334 Patent], claims 6-9
`
`EX1007 [Brantigan], Fig. 6 (annotated)
`
`Source: Pet., 70-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`97
`
`
`
`Claim 18: Brantigan, Michelson, and Berry Disclose Claimed Dimensions
`
`EX1001 [’334 Patent] claim 18
`
`EX1022 [Berry], Table 1
`
`L4-L5 Implant Width Range
`L4 (lower (“D”)) –> (35.6 – 3.1) / 2 = 16.25 mm*
`L5 (upper (“E”)) –> (35.1 + 2.8) / 2 = 18.95 mm
`
`Longitudinal Length
`L4 (lower (“C”)) –> 50.9 – 4.6 = 46.3 mm, which is “at least two and a half
`times greater than said maximum lateral width” as required by claim 1
`
`* The value “16.15 mm” at Petition 74 should
`properly be 16.25 mm as calculated above
`
`Source: Pet., 73-74
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`98
`
`
`
`Motivation to Combine
`Brantigan, Michelson, Baccelli, and Berry
`
`99
`
`
`
`Motivation to Combine: Increased Safety and Decreased Invasiveness
`
`EX1007 [Brantigan], 3:30-35
`
`EX1032 [Michelson], 3:61-65
`
`EX1007 [Brantigan], 7:4-6
`
`Source: Pet., 43-48
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`100
`
`
`
`Motivation to Combine: Modular Implants with Vertebral Dimensions
`
`EX1007 [Brantigan], 1:18-21
`
`EX1032 [Michelson], Fig. 19
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 43-48
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`101
`
`
`
`Motivation to Combine: Markers to Identify Implant Position
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 43-48
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`102
`
`
`
`Patent Owner’s Argument Against Motivation to Combine
`
`POR, 55
`
`Source: Reply, 2-3
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`103
`
`
`
`Patent Owner’s Expert Dr. Youssef on State of the Art
`
`EX1050, 53:16-25
`
`Source: Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`104
`
`
`
`Patent Owner’s Expert Dr. Youssef on State of the Art
`
`EX1050, 54:1-15
`
`Source: Supp. Sur-Sur-Reply, 2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`105
`
`
`
`Marker Argument Not Hindsight: POSAs Knew Benefits
`
`EX1002 [Branch Decl.], ¶ 27
`
`EX1054 [McAfee], Fig. 4
`
`Source: Pet., 43-48, Reply, 2-3
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`106
`
`
`
`IPR2019-00546
`IPR2019-00546
`
`’334 Patent - Grounds 1 and 2
`'334 Patent - Grounds 1 and 2
`
`107
`
`
`
`Overview of Grounds
`
`The ’334 patent (-0546)
`
`Ground
`
`Claims
`
`Basis
`
`1
`
`2
`
`16
`
`16
`
`Obvious over Frey, Michelson, and Baccelli
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`108
`
`
`
`Previous Petitioner Relied On Different Disclosure For Claim 16
`
`EX1005 [Federal Circuit Op. IPR2019-00507, -00508], 5
`
`Source: Pet., 18-19
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`Board: claim 16 unpatentable
`
`• Federal Circuit remanded for
`further proceedings
`
`Prior Petitioner did not:
`
`• cite the same evidence Federal
`Circuit relied on to invalidate
`claim 1 for claim 16
`
`• cite Michelson’s long-and-
`narrow modular disclosure for
`claim 16
`
`Federal Circuit did not:
`
`• address Michelson’s long-and-
`narrow modular disclosure for
`claim 16
`
`109
`
`
`
`Federal Circuit Previously Remanded Claim 16–Parties Settled
`
`EX1005 [Federal Circuit Op. IPR2019-00507, -00508], 17
`
`Source: Pet., 1-2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`110
`
`
`
`Claim 16 Adds Only A Fourth Marker To Central Region of Claim 1
`
`Ground
`
`Claims
`
`Basis
`
`The ’334 patent (-0361)
`
`1
`
`2
`
`6-9 and 18
`
`Obvious over Frey, Michelson, and Berry
`
`6-9 and 18
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`Ground
`
`Claims
`
`Basis
`
`The ’334 patent (-0546)
`
`1
`
`2
`
`16
`
`16
`
`Obvious over Frey, Michelson, and Baccelli
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`111
`
`
`
`Baccelli Discloses Claimed Fourth Marker
`
`EX1001 [’334 Patent], claim 16
`
`Pet., 45 citing Ex. 1008, Figs. 1–2 (annotated)
`
`Source: Pet., 63-70
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`112
`
`
`
`Motivation to Combine:
`(1) Frey, Michelson, and Baccelli
`(2) Brantigan, Michelson, Baccelli, and Berry
`
`113
`
`
`
`Motivation to Combine: Modular Implants with Markers
`
`EX1040 [Frey], [0156]
`
`EX1008 [Baccelli], Figs. 1, 2 (annotated)
`
`EX1032 [Michelson], Fig. 19
`
`Source: Pet., 29-31
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`114
`
`
`
`Motivation to Combine: Modular Implants with Vertebral Dimensions
`
`EX1007 [Brantigan], 1:18-21
`
`EX1032 [Michelson], Fig. 19
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 38-42, 54-57
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`115
`
`
`
`Motivation to Combine: Markers to Identify Implant Position
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 38-42
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`116
`
`
`
`Estoppel Applies
`Estoppel Applies
`
`117
`
`
`
`Collateral Estoppel Applies In Administrative Context
`
`Board decisions holding certain
`claims unpatentable “affirmed by
`[the Federal Circuit], are binding
`in this proceedings, as a matter
`of collateral estoppel.”
`
`Inc. v. CF CRESPE LLC, 880 F.3d 1373,
`MaxLinear,
`1376 (Fed. Cir. 2018)
`
`Source: IPR2019-00361 Pet., 32; Reply 6-8; IPR2019-00546 Pet., 31-32; Reply, 6-8
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`Issue is identical
`Claim 1 of the ‘334 patent invalidated over Frey and
`Michelson in IPR2013-00507
`
`Issue was actually litigated, and resolution was
`essential to a final judgment
`Patent Owner did not appeal Federal Circuit’s affirmance of
`claim 1 invalidity
`
`Patent Owner had full and fair opportunity to litigate
`Patent Owner participated at the Board, Federal Circuit and
`opted not to appeal to Supreme Court
`
`Equities favor preclusion
`Congress intended agencies and courts to issue definitive
`judgments
`B & B Hardware, Inc. v. Hargis Indus., Inc., 575 U.S. 138, 148 (2015)
`Sur-reply in IPR2013-00507 would have made no
`difference because Patent Owner was on notice
`Changes in law do not prohibit preclusion
`
`118
`
`
`
`IPR2019-00362
`IPR2019-00362
`
`’156 Patent - Ground 1
`'156 Patent - Ground 1
`
`119
`
`
`
`Overview of Grounds
`
`The ’156 patent (-0362)
`
`Ground
`
`Claims
`
`Basis
`
`1
`
`1-3, 5, 9, 10, 12-21,
`23, 24, and 27
`
`Obvious over Brantigan, Baccelli, and Berry
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`120
`
`
`
`‘334 Patent and ‘156 Patent Challenged Claims Substantially Similar
`
`IPR2019-00362 EX1001 [’156 patent], claim 1
`
`Dependent claims directed to:
`
`• radiopaque marker orientation
`
`• “receiving aperture” for mounting tool
`
`• width of approximately 18 mm
`
`• PEEK composition
`
`• shape of implant and fusion apertures
`
`• medial support
`
`• anti-migration elements
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`121
`
`
`
`Claim 1: Brantigan “A Spinal Fusion Implant”
`
`EX1001 [’156 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`Source: Pet., 33-41
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`122
`
`
`
`Claim 1: Brantigan Discloses Claimed Dimensions
`
`EX1001 [’156 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`Source: Pet., 41-44
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`123
`
`
`
`Claim 1: Brantigan Discloses Claimed Dimensions
`
`EX1007 [Brantigan] 5:30-35
`
`EX1007 [Brantigan], 1:18-21
`
`EX1007 [Brantigan], 1:68-2:4
`
`Source: Pet., 56-57, 61-64
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`124
`
`
`
`Claim 1: Brantigan Discloses Claimed “Fusion Aperture”
`
`EX1001 [’156 Patent], claim 1
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated)
`
`POR: Fig. 1 is “unassembled precursor”
`requiring connecting bar 15
`
`• Brantigan does not require connecting bar
`• In any case, aperture length is greater than
`aperture width
`
`Source: Pet., 46-48; POR 17, 28; Reply, 8-10
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`125
`
`
`
`Claims 1–3: Baccelli Discloses Marker Limitations
`
`EX1001 [’156 Patent], claim 1
`
`EX1001 [’156 Patent], claims 2–3
`
`EX1008 [Baccelli], Figs. 1–2 (annotated)
`
`Source: Pet., 49-54
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`126
`
`
`
`Claims 1–3: Baccelli Discloses Marker Limitations
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 49-54
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`127
`
`
`
`Claim 5: Brantigan and Berry Disclose Claimed Dimensions
`
`EX1001 [’156 Patent], claim 5
`
`EX1007 [Brantigan], Fig. 8
`
`Lumbar longitudinal length is greater than 40 mm
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 54-56
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`128
`
`
`
`Claim 9: Brantigan and Berry Disclose Claimed Dimensions
`
`EX1001 [’156 Patent], claim 9
`
`EX1022 [Berry], Table 1
`
`EX1007 [Brantigan], 1:68-2:4
`
`Source: Pet., 56
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`129
`
`
`
`Claims 10, 12–13: Brantigan Discloses Claimed Limitations
`
`EX1001 [‘156 Patent], claims 10, 12, 13
`
`EX1007 [Brantigan], 3:9-12
`
`EX1007 [Brantigan], Figs. 7, 8, 10 (annotated)
`
`Source: Pet., 57-58
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`130
`
`
`
`Claim 14–18: Brantigan Discloses Claimed Limitations
`
`EX1001 [’156 Patent], claims 14, 15
`
`EX1001 [’156 Patent], claims 16-18
`
`EX1007 [Brantigan], Figs. 7, 8, 10 (annotated)
`
`Source: Pet., 59-62
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`131
`
`
`
`Claim 19–21: Brantigan and Baccelli Disclose Claimed Limitations
`
`EX1001 [’156 Patent], claims 19-21
`
`EX1007 [Brantigan], 4:15-18
`
`EX1007 [Brantigan], Fig. 10 (annotated)
`
`EX1008 [Baccelli], [0020]-[0021]
`
`Source: Pet., 63-65
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`132
`
`
`
`Claims 23–24: Brantigan and Berry Disclose Claimed Limitations
`
`EX1001 [‘156 Patent], claims 23-24
`
`EX1007 [Brantigan], Figs. 1, 6 (annotated), 2:19-22
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 66-67
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`133
`
`
`
`Claim 27: Brantigan Discloses Osteoinductive Material
`
`EX1001 [’156 Patent], claim 27
`
`EX1007 [Brantigan], Fig. 11
`
`EX1007 [Brantigan], 2:14-18
`
`EX1007 [Brantigan], 6:37-40
`
`Source: Pet., 68-69
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`134
`
`
`
`Motivation to Combine
`Brantigan, Baccelli, and Berry
`
`135
`
`
`
`Motivation to Combine: Implants Sized to Conform with Vertebrae
`
`EX1007 [Brantigan], 3:30-35
`
`EX1007 [Brantigan], 1:18-21
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 28-30
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`136
`
`
`
`Motivation to Combine: Markers to Identify Implant Position
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 30-33
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`137
`
`
`
`IPR2019-00362
`IPR2019-00362
`
`’156 Patent - Ground 2
`'156 Patent - Ground 2
`
`138
`
`
`
`Overview of Grounds
`
`The ’156 patent (-0362)
`
`Ground
`
`Claims
`
`Basis
`
`2
`
`9
`
`Obvious over Brantigan, Baccelli, Berry, and Michelson
`
` Brantigan discloses modular (multiple) implants in the disc space
`
` Michelson discloses modular, long-and-narrow implants
`
` Berry discloses vertebral dimensions
`
` Baccelli discloses claimed markers
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`139
`
`
`
`Claim 9: Brantigan’s Implants Sized to Conform with Vertebrae
`
`IPR2019-00362 EX1001 [’156 Patent], claim 9
`
`EX1007 [Brantigan], 1:18-21
`
`EX1007 [Brantigan], 1:68-2:4
`
`Source: Pet., 70-75
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`140
`
`
`
`Claim 9: Brantigan Discloses Modular Implants
`
`EX1007 [Brantigan], 2:4-11
`
`Source: Pet., 70-75
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`141
`
`
`
`Claim 9: Michelson Discloses Modular Implants
`
`EX1032 [Michelson], 10:48-59
`
`Source: Pet., 40-43
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`142
`
`
`
`Claim 9: Michelson’s Width "approximates depth of the vertebrae”
`
`EX1032 [Michelson], 10:36-40
`
`Source: Pet., 30
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`143
`
`
`
`Claim 9: Berry Discloses “Direct Dimensional Measurements”
`
`IPR2019-00362 EX1001 [’156 Patent], claim 9
`
`EX1022 [Berry], Table 1
`
`Petitioner never suggested inserting 2
`implants each having 18.95 mm width
`
`L4-L5 Implant Width Range
`L4 (lower (“D”)) –> (35.6 – 3.1) / 2 = 16.25 mm*
`L5 (upper (“E”)) –> (35.1 + 2.8) / 2 = 18.95 mm
`
`*The value “16.15 mm” at Petition 75 should properly be 16.25 mm as calculated above.
`
`Source: Pet., 70-75; Reply 16
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`144
`
`
`
`Motivation to Combine
`Brantigan, Baccelli, Berry, and Michelson
`
`145
`
`
`
`Motivation to Combine: Increased Safety and Decreased Invasiveness
`
`EX1007 [Brantigan], 3:30-35
`
`EX1032 [Michelson], 3:61-65
`
`EX1007 [Brantigan], 7:4-6
`
`Source: Pet., 69-70
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`146
`
`
`
`Motivation to Combine: Modular Implants with Vertebral Dimensions
`
`EX1007 [Brantigan], 1:18-21
`
`EX1032 [Michelson], Fig. 19
`
`EX1022 [Berry], Table 1
`
`Source: Pet., 28-30
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`147
`
`
`
`Motivation to Combine: Markers to Identify Implant Position
`
`EX1008 [Baccelli], [0050]
`
`EX1008 [Baccelli], [0051]
`
`Source: Pet., 30-33
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`148
`
`
`
`Lack of Nexus Forecloses
`Secondary Considerations
`
`149
`
`
`
`Objective Indicia Arguments Do Not Establish Non-Obviousness
`
` Patent Owner relies on several secondary considerations arguments – each lacks nexus
`
` Development of XLIF and CoRoent XL
`
`• Success of XLIF is not the same success of CoRoent implant
`
` Skepticism
`
`• No evidence that skepticism linked to implant size, rather than access path
`
` Commercial Success
`
`• No evidence that implant sales are separate from “success” of unclaimed XLIF features
`
`• No evidence that implant sales are separate from surgeon education and training
`
` Copying
`
`• No evidence of copying
`
`• “Not every competing product that arguably falls within the scope of the patent is evidence of
`copying. Otherwise every infringement suit would automatically confirm the nonobviousness of
`the patent.” - Iron Grip Barbell Co. v. USA Sports, Inc., 392 F.3d 1317, 1325 (Fed. Cir 2004)
`Source: Reply, 17-20
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`150
`
`
`
`Dr. Youssef: ”XLIF” Comprises Multiple Products
`
`EX2055 [Youssef Decl.], ¶ 84
`
`Source: Reply, 17-20
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`151
`
`
`
`Mr. Link: ”XLIF” Success Due to Surgeon Training
`
`EX1065 [Link Decl.], ¶ 24
`
`Source: Reply, 17-20
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`152
`
`